Ignite Creation Date:
2026-03-26 @ 3:16 PM
Ignite Modification Date:
2026-03-30 @ 12:09 AM
Study NCT ID:
NCT07470203
Status:
NOT_YET_RECRUITING
Last Update Posted:
2026-03-13
First Post:
2026-03-09
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Pyrotinib Combined With Trastuzumab and Pertuzumab for Maintenance Therapy in HER2-Positive Advanced Breast Cancer
Sponsor:
Peking University Cancer Hospital & Institute
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2026-03-31
Start Date Type:
ESTIMATED
Primary Completion Date:
2029-03-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2029-09-30
Completion Date Type:
ESTIMATED
First Submit Date:
2026-03-09
First Submit QC Date:
None
Study First Post Date:
2026-03-13
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2026-03-09
Last Update Post Date:
2026-03-13
Last Update Post Date Type:
ACTUAL